publication date: Dec. 20, 2010

In this issue: 

As patients worry about COX-2 inhibitors, scientists and FDA review toxicity data.

Also in this 8-page issue: M.D. Anderson Cancer Center wins ninth SPORE grant, this time for melanoma research.

Fox Chase Cancer Center plans $1 billion expansion that would double its size.

Human Genome Project publishes its final product.

Download (PDF 361KB)

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.